Yi Chen, an analyst from H.C. Wainwright, reiterated the Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report). The associated price target remains the same with $9.00. Yi
Yi Chen, an analyst from H.C. Wainwright, reiterated the Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report). The associated price target remains the same with $9.00. Yi
Alpha Tau Medical Ltd (DRTS) has released an update. Alpha Tau Medical Ltd. has been accepted into the FDA’s Total Product Life Cycle Advisory Program, aiming to expedite the market
Alpha Tau (DRTS) Medical שיתפו כי קבלה זו תעזור להאיץ את הגישה לשוק עבור ה-Alpha DaRT, טיפול לחולים עם גליובלסטומה מולטיפורמה (GBM) חוזרת, סוג של סרטן מוח. זה מגיע לאחר
Alpha Tau (DRTS) Medical announced that it has been accepted into the prestigious Total Product Life Cycle, TPLC, Advisory Program, TAP, Pilot of the U.S. Food and Drug Administration, FDA,
Yi Chen, an analyst from H.C. Wainwright, reiterated the Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report). The associated price target remains the same with $9.00. Yi